Anti-allergic drug azelastine could directly bind to and inactivate ARF1 to block the IQGAP1-mediated ERK signaling, thus inhibiting mitochondrial fission to suppress CRC proliferation in vitro and in vivo. This evidence concerns the gene MAPK1 and colorectal carcinoma.